Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03035565 · ClinicalTrials.gov registry record · NA
Cognitive Intervention to Improve Memory in Heart Failure Patients
A NA study, sponsored by Indiana University.
- Completed
- Registry status
- NA
- Development phase
- 276
- Enrollment target
NCT03035565: Completed NA study, sponsored by Indiana University.
NCT03035565 is a NA study that has completed, run by Indiana University. The registered enrollment target is 276 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03035565, a NA study, has completed, sponsored by Indiana University.
- COMPLETED
- Registry status
- NA
- Development phase
- 276 participants
- Enrollment target
Study Summary
Cognitive Intervention to Improve Memory in Heart Failure patients
Primary Outcome
Change in delayed recall memory as measured by Hopkins Verbal Learning Test
Interventions
- BEHAVIORAL Computerized Cognitive Training with Brain HQ
- BEHAVIORAL Computerized Crossword Puzzles
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 276 participants |
| Start Date | 2017-02-22 |
| Est. Completion | 2021-09-30 |
| Phase | NA |
What the finished NCT03035565 record still lists
NCT03035565 is an interventional study that assigns participants to a tested intervention. The registered 276 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (80% lower).
The record links to 0 conditions, and to 2 interventions - of which Computerized Cognitive Training with Brain HQ is the first listed.
NCT03035565 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03035565 about?
NCT03035565 is a clinical study titled "Cognitive Intervention to Improve Memory in Heart Failure Patients". Cognitive Intervention to Improve Memory in Heart Failure patients
What is the current status of trial NCT03035565?
This trial is currently completed. It is a NA study. The enrollment target is 276 participants. The study started on 2017-02-22. Estimated completion is 2021-09-30.
What interventions are being tested in trial NCT03035565?
The interventions under investigation include: Computerized Cognitive Training with Brain HQ (BEHAVIORAL), Computerized Crossword Puzzles (BEHAVIORAL).
Who is sponsoring clinical trial NCT03035565?
This trial is sponsored by Indiana University, which has 890 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03035565's enrollment target sits among peer trials
276 383rd of 2000 higher than 1,618 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01371630 · 276 participants · Phase 1
Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia
- NCT04192344 · 276 participants · Phase 1
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of ABSK-021 in Patients With Advanced Solid Tumor
- NCT05294991 · 276 participants · NA
Wellness App for Sleep Disturbance in Hematological Cancer Patients
- NCT05610852 · 276 participants · NA
Single-Port Transvesical Partial Prostatectomy Versus High Intensity Focused Ultrasound
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI